First Time Loading...

Atreca Inc
NASDAQ:BCEL

Watchlist Manager
Atreca Inc Logo
Atreca Inc
NASDAQ:BCEL
Watchlist
Price: 0.0921 USD 2.33% Market Closed
Updated: Jun 1, 2024

Atreca Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Atreca Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Atreca Inc
NASDAQ:BCEL
Cash Equivalents
$30.8m
CAGR 3-Years
-42%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$18.1B
CAGR 3-Years
23%
CAGR 5-Years
30%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$4.7B
CAGR 3-Years
5%
CAGR 5-Years
-23%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9.7B
CAGR 3-Years
17%
CAGR 5-Years
6%
CAGR 10-Years
10%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$9.2B
CAGR 3-Years
13%
CAGR 5-Years
26%
CAGR 10-Years
36%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2.6B
CAGR 3-Years
22%
CAGR 5-Years
9%
CAGR 10-Years
19%

See Also

What is Atreca Inc's Cash Equivalents?
Cash Equivalents
30.8m USD

Based on the financial report for Dec 31, 2022, Atreca Inc's Cash Equivalents amounts to 30.8m USD.

What is Atreca Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
30%

Over the last year, the Cash Equivalents growth was -67%. The average annual Cash Equivalents growth rates for Atreca Inc have been -42% over the past three years , 30% over the past five years .